Adriana Ammassari

Medicine & Life Sciences

1. HIV 100%
2. Highly Active Antiretroviral Therapy 60%
3. Acquired Immunodeficiency Syndrome 48%
4. HIV-1 37%
5. HIV Infections 29%
6. Progressive Multifocal Leukoencephalopathy 27%
7. Ritonavir 25%
8. CD4 Lymphocyte Count 22%
9. Therapeutics 21%
10. Italy 20%
11. Tenofovir 19%
12. Viral Load 18%
13. Raltegravir Potassium 18%
14. DNA 17%
15. RNA 17%
16. Emtricitabine 16%
17. Protease Inhibitors 16%
18. Viremia 14%
19. JC Virus 14%
20. Darunavir 12%
21. Cohort Studies 12%
22. Cerebrospinal Fluid 12%
23. Atazanavir Sulfate 12%
24. Reverse Transcriptase Inhibitors 12%
25. Lymphoma 11%
26. Confidence Intervals 11%
27. efavirenz 11%
28. Pharmaceutical Preparations 11%
29. Human Herpesvirus 4 10%
30. Hepacivirus 10%
31. Survival 10%
32. Polymerase Chain Reaction 9%
33. Integrases 9%
34. Rilpivirine 8%
35. Encephalitis 8%
36. Cidofovir 8%
37. Nucleosides 7%
38. Pneumocystis Pneumonia 7%
39. Drug Resistance 7%
40. Central Nervous System 7%
41. Observational Studies 7%
42. Antiviral Agents 7%
43. Brain 6%
44. Patient Compliance 6%
45. Toxoplasma 6%
46. Pyrimethamine 6%
47. Sofosbuvir 6%
48. Treatment Failure 6%
49. Physicians 6%
50. Nevirapine 5%